Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection.
10.3760/cma.j.cn501113-20191227-00482
- VernacularTitle:非酒精性脂肪性肝病与乙型肝炎病毒既往感染者肝癌发生关系的研究
- Author:
Li CHEN
1
;
Kai Feng WANG
1
;
Zhou ZHAO
1
;
Qiu Hong YOU
1
;
Yao Bo WU
1
;
Jian SUN
1
Author Information
1. State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Hepatocellular carcinoma;
Non-alcoholic fatty liver disease
- MeSH:
Carcinoma, Hepatocellular/epidemiology*;
Hepatitis B/epidemiology*;
Hepatitis B Surface Antigens;
Hepatitis B virus;
Humans;
Liver Neoplasms/epidemiology*;
Middle Aged;
Non-alcoholic Fatty Liver Disease/epidemiology*;
Retrospective Studies;
Risk Factors
- From:
Chinese Journal of Hepatology
2022;30(1):52-56
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the role of nonalcoholic fatty liver disease (NAFLD) in the development of hepatocellular carcinoma (HCC) in patients with prior hepatitis B virus infection (HBsAg-negative and anti-HBC-positive). Methods: 1605 hospitalized patients who were first diagnosed with HCC at Nanfang Hospital between 2015 to 2017 were retrospectively studied. Patients who developed HCC on the basis of active HBV infection (HBsAg-positive, anti-HBc positive) were used as control. Multivariate logistic regression model was used to analyze the relationship between NAFLD and HCC in patients with prior hepatitis B virus infection. Results: Among HCC patients with both HBsAg and anti-HCV negative, the proportion of prior HBV infection accounted for 86.7%. NAFLD prevalence was higher in patients with HCC based on prior HBV infection than active HBV infection (19.7% vs. 8.5%, P < 0.001). After adjusting for gender, age, hypertension, alanine aminotransferase, and liver cirrhosis, patients with HCC based on prior HBV infection were more likely to develop NAFLD (OR: 2.29, 95% CI: 1.40-3.74), and this phenomenon was observed only in patients with non-cirrhosis (OR: 5.26, 95% CI: 2.53-10.96) and aged≥50 years (OR: 2.36, 95% CI: 1.33-4.20). Conclusion: NAFLD may be a risk factor for HCC in a previously infected patients with HBV, especially in non-cirrhotic and population aged≥50 years.
